6 completed, 4 unknown, 2 recruiting, 1 not yet recruiting. 3 Not applicable, 3 Phase 2, 3 Phase 4, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Completed 2, Terminated 1 |
| Phase 2 | 3 | Completed 2, Not yet recruiting 1 |
| Phase 4 | 3 | Unknown 2, Recruiting 1 |
| Phase 1 | 1 | Not yet recruiting 1 |
| Phase 3 | 1 | Completed 1 |
Follow Hypertensive Nephropathy: new trials by email Literature Review of Hypertensive Nephropathy trials Research Report on Hypertensive Nephropathy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Mesenchymal Stem Cells for Chronic Kidney Diseases 0.9% sodium chloride, MSCs - Kidney Disease, Chronic, Diabetic Kidney Disease (DKD) | Phase 1 / Phase 2 | Not yet recruiting | The First Affiliated Hospital of Air Force Medicial University | 32 | 2026-01-01 | 2025-12-24 |
| ACE Reno, Pico Cell Matrix and Its Effect on eGFR in Chronic Kidney Diseases ACE Reno - Hypertensive Nephropathy, Auto Immune Disorders | Phase 4 | Recruiting | Ace Cells Lab Limited | 300 | 2025-09-20 | 2025-09-23 |
| Role of QRX-3 in Chronic Kidney Disease Patients in Outpatients Clinics QRX-3 - Chronic Kidney Disease Stages 3-5, Diabetic Kidney Disease | Phase 2 | Completed | Ebima Clifford Okundaye | 127 | 2023-03-01 | 2025-09-08 |
| China Kidney Patient Trials Network Kidney Diseases | Recruiting | George (Beijing) Clinical Research Co. Ltd. | 1200 | 2021-09-27 | 2023-03-06 | |
| Global Kidney Patient Trials Network Kidney Diseases | Completed | The George Institute | 5999 | 2020-05-05 | 2025-12-15 | |
| Effectiveness of Implementation of a Patient-centered Self-management Program in Patients With Hypertensive Nephropathy PCSMP - Hypertensive Nephropathy, Self-management | Not applicable | Completed | National Taipei University of Nursing and Health Sciences | 70 | 2019-12-02 | 2022-04-07 |
| Nighttime Losartan in Continous Ambulatory Peritoneal Dialysis (NVCAPD) Losartan - Hypertension,Nephropathy | Phase 4 | Unknown | Fifth Affiliated Hospital, Sun Yat-Sen University | 68 | 2018-12-01 | 2018-11-05 |
| Nighttime Valsartan in Hemodialysis Hypertension Valsartan - Hypertension;Nephropathy | Phase 4 | Unknown | Fifth Affiliated Hospital, Sun Yat-Sen University | 68 | 2018-11-01 | 2018-07-20 |
| Whole Exome Sequencing in CKD Hypertension whole exome sequencing analysis - Hypertension;Nephropathy | Unknown | Fifth Affiliated Hospital, Sun Yat-Sen University | 4000 | 2018-06-01 | 2018-10-24 | |
| Effects of Nocturnal Hypertension on Sleep Quality in Renal Transplant Recipients questionnaire administration - Hypertension; Nephropathy, Renal Transplant | Unknown | Federico II University | 200 | 2017-06-01 | 2018-08-29 | |
| Ayurvedic Management of Chronic Kidney Disease Ayurveda treatment - Diabetic Nephropathy, Hypertensive Nephropathy | Not applicable | Completed | J.S. Ayurveda College | 521 | 2014-01-01 | 2022-08-12 |
| Treatment of Resistant Hypertension by Renal Sympathetic Denervation in Patients Undergoing Dialysis Therapy Renal nerve denervation - Hypertension Secondary to Renal Disease | Not applicable | Terminated | Turku University Hospital | 6 | 2013-05-01 | 2021-03-10 |
| African American Study of Kidney Disease and Hypertension ABPM Pilot Study USUAL - take your BP Meds as you usually do, HS DOSING, ADD On Dosing - Hypertensive Renal Disease | Phase 2 / Phase 3 | Completed | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 180 | 2007-11-01 | 2012-04-16 |
| Sympathetic Activity and Cardiometabolic Complications Catecholamine; Overproduction, Catecholamine; Secretion | Completed | University of Turin, Italy | 1380 | 2007-09-01 | 2020-07-31 |
Renal Insufficiency, Chronic (8) · Diabetic Nephropathies (6) · Kidney Diseases (4) · Kidney Failure, Chronic (3) · Glomerulonephritis (2) · Glomerulonephritis, IGA (2) · Glomerulonephritis, Membranous (2) · Glomerulosclerosis, Focal Segmental (2) · Hypertension (2) · Nephrosis, Lipoid (2) · Diabetes Mellitus, Type 2 (1) · Essential Hypertension (1) · Metabolic Syndrome (1) · Proteinuria (1)
Pathological Conditions, Signs and Symptoms (11) · Female Urogenital Diseases (10) · Female Urogenital Diseases and Pregnancy Complications (10) · Male Urogenital Diseases (10) · Urogenital Diseases (10) · Urologic Diseases (10) · Chronic Disease (9) · Disease Attributes (9) · Pathologic Processes (9) · Renal Insufficiency (9) · Diabetes Mellitus (7) · Endocrine System Diseases (7) · Diabetes Complications (6) · Kidney Diseases (6) · Cardiovascular Diseases (3)
Losartan (1) · Sodium Chloride (1) · Valsartan (1) · lactitol (1)
Fifth Affiliated Hospital, Sun Yat-Sen University (3) · Ace Cells Lab Limited (1) · Ebima Clifford Okundaye (1) · Federico II University (1) · George (Beijing) Clinical Research Co. Ltd. (1) · J.S. Ayurveda College (1) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1) · National Taipei University of Nursing and Health Sciences (1) · The First Affiliated Hospital of Air Force Medicial University (1) · The George Institute (1) · Turku University Hospital (1) · University of Turin, Italy (1)
China (2) · Italy (2) · United States (2) · Australia (1) · Egypt (1) · Finland (1) · India (1) · Taiwan (1)
Cheng Wang, Director (3) · DeAnna Cheek, MD (1) · Dr. Alaa Abdelkarim M Fouad, MRCPUK SEC (1) · Ezio Ghigo, MD (1) · Francis B. Gabbai, MD (1) · Gabriel Contreras, MD (1) · George Bakris, MD (1) · Geraldine Bichier, MD (1) · Hiddo Lambers Heerspink (1) · Jackson T. Wright, Jr., MD, Ph.D., FACP (1) · Janice Lea, MD (1) · Julia A. Lewis, MD (1) · Keith Norris, MD (1) · Kenneth Jamerson, MD (1) · Lawrence Appel, MD, MPH (1)
PMID 23172931, PMID 26867061, PMID 28830083, PMID 33942419, PMID 34964363, PMID 39661388